Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 855  
This article has been cited by
1The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice
Emma J. Haagensen,Huw D. Thomas,Ian Wilson,Suzannah J. Harnor,Sara L. Payne,Tommy Rennison,Kate M. Smith,Ross J. Maxwell,David R. Newell,Seema Singh
PLoS ONE.2013;8(12)e81763
[DOI]
2Mechanisms shaping the role of ERK1/2 in cellular sene scence (Review)
Junrong Zou,Tingting Lei,Pei Guo,Jason Yu,Qichao Xu,Yunfei Luo,Rong Ke,Deqiang Huang
Molecular Medicine Reports.2018;8(12)e81763
[DOI]
3FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study
Marie Benzon Mogensen,Annika Loft,Marianne Aznar,Thomas Axelsen,Ben Vainer,Kell Osterlind,Andreas Kjaer
EJNMMI Research.2017;7(1)e81763
[DOI]
4Novel drug discovery opportunities for colorectal cancer
Joshua C Curtin
Expert Opinion on Drug Discovery.2013;8(9)1153
[DOI]
5MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim
Xiao-Bin Lv,Xing Zhang,Lan Deng,Ling Jiang,Wei Meng,Zhigang Lu,Xiuju Wang
Cell Biology International.2014;38(4)435
[DOI]
63'-Deoxy-3-18F-Fluorothymidine and 18F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies
Jeong Eun Kim,Sun Young Chae,Jwa Hoon Kim,Hwa Jung Kim,Tae Won Kim,Kyu-pyo Kim,Sun Young Kim,Jae-Lyun Lee,Seung Jun Oh,Jae Seung Kim,Jin-Sook Ryu,Dae Hyuk Moon,Yong Sang Hong
European Journal of Nuclear Medicine and Molecular Imaging.2019;46(8)1713
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal